Shattuck Labs, Inc. (STTK)
- Previous Close
1.1600 - Open
1.1600 - Bid 1.0500 x 100
- Ask 1.1200 x 100
- Day's Range
1.0800 - 1.1950 - 52 Week Range
0.6920 - 6.9900 - Volume
84,898 - Avg. Volume
171,469 - Market Cap (intraday)
51.735M - Beta (5Y Monthly) 1.73
- PE Ratio (TTM)
-- - EPS (TTM)
-1.3500 - Earnings Date Jul 30, 2025 - Aug 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.46
Shattuck Labs, Inc., a biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases. The company's lead product candidate includes SL-325, a DR3 blocking monoclonal antibody, which activates immune responses through binding a single receptor, DR3; and SL-425. It also develops multiple preclinical DR3-based bispecific antibodies for the treatment of inflammatory bowel disease; and a series of bispecific antibodies targeting DR3 and other clinically validated targets. In addition, the company is involved in the advancement of its lead TRIM7 inhibitors through preclinical development as future internal pipeline candidates in oncology. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.
www.shattucklabs.comRecent News: STTK
View More
Performance Overview: STTK
Trailing total returns as of 6/11/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STTK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STTK
View MoreValuation Measures
Market Cap
55.57M
Enterprise Value
-2.14M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
13.14
Price/Book (mrq)
0.84
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-41.77%
Return on Equity (ttm)
-71.90%
Revenue (ttm)
4.61M
Net Income Avi to Common (ttm)
-70.61M
Diluted EPS (ttm)
-1.3500
Balance Sheet and Cash Flow
Total Cash (mrq)
60.9M
Total Debt/Equity (mrq)
4.72%
Levered Free Cash Flow (ttm)
-30.34M
Research Analysis: STTK
View MoreResearch Reports: STTK
View MoreDaily – Vickers Top Buyers & Sellers for 10/09/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 06/27/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 04/27/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.